Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance

Drug and Alcohol Dependence

Volumn 92, Issue 1-3, 2008, Pages 282-285

  Stoops, William W ^a   Blackburn, John W ^a   Hudson, David A ^a   Hays, Lon R ^a   Rush, Craig R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Atomoxetine; Cocaine; Humans; Pharmacotherapy; Physiological effects

Indexed keywords

ATOMOXETINE; COCAINE;

ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; SUBSTITUTION THERAPY; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, INTRANASAL; ADRENERGIC UPTAKE INHIBITORS; ADULT; BLOOD PRESSURE; COCAINE; COCAINE-RELATED DISORDERS; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HEART RATE; HUMANS; MALE; PROPYLAMINES;

EID: 36749001183     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.07.005     Document Type: Article

References (23)

1. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., Morin S.M., Gehlert D.R., and Perry K.W. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27 (2002) 699-711
2. Dackis C.A., Kampman K.M., Lynch K.G., Pettinati H.M., and O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30 (2005) 205-211
3. Di Marino M.E., Haberny K.A., Felch L.J., Walsh S.L., Preston K.L., and Bigelow G.E. Development of a subject-rated rating scale sensitive to acute cocaine administration. In: Harris L. (Ed). Problems of Drug Dependence, 1997: Proceedings of the 59th Annual Scientific Meeting. National Institute on Drug Abuse Research Monograph Series. Rockville, MD (1998) 139
4. Dudish-Poulsen S.A., and Hatsukami D.K. Dissociation between subjective and behavioral responses after cocaine stimuli presentations. Drug Alcohol Depend. 47 (1997) 1-9
5. Farid N.A., Bergstrom R.F., Ziege E.A., Parli C.J., and Lemberger L. Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjects. J. Clin. Pharmacol. 25 (1985) 296-301
6. Fleckenstein A.E., Gibb J.W., and Hanson G.R. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur. J. Pharmacol. 406 (2000) 1-13
7. Gasior M., Bergman J., Kallman M.J., and Paronis C.A. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology 30 (2005) 758-764
8. Grabowski J., Rhoades H., Schmitz J., Stotts A., Daruzska L.A., Creson D., and Moeller F.G. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J. Clin. Psychopharmacol. 21 (2001) 522-526
9. Grabowski J., Rhoades H., Stotts A., Cowan K., Kopecky C., Dougherty A., Moeller F.G., Hassan S., and Schmitz J. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29 (2004) 969-981
10. Heil S.H., Holmes H.W., Bickel W.K., Higgins S.T., Badger G.J., Laws H.F., and Faries D.E. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend. 67 (2002) 149-156
11. Johanson C.E., and Barrett J.E. The discriminative stimulus effects of cocaine in pigeons. J. Pharmacol. Exp. Ther. 267 (1993) 1-8
12. Johanson C.E., and Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41 (1989) 3-52
13. Kleven M.S., Anthony E.W., and Woolverton W.L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 254 (1990) 312-317
14. Kuczenski R., and Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68 (1997) 2032-2037
15. Lile J.A., Stoops W.W., Durell T.M., Glaser P.E., and Rush C.R. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Exp. Clin. Psychopharmacol. 14 (2006) 136-147
16. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., and Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr. Scand. Suppl. 334 (1987) 1-100
17. Oliveto A.H., Bickel W.K., Hughes J.R., Shea P.J., Higgins S.T., and Fenwick J.W. Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J. Pharmacol. Exp. Ther. 261 (1992) 885-894
18. Rush C.R., Stoops W.W., Hays L.R., Glaser P.E.A., and Hays L.S. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J. Pharmacol. Exp. Ther. 306 (2003) 195-204
19. Spealman R.D. Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther. 275 (1995) 53-62
20. Spencer T., Biederman J., Heiligenstein J., Wilens T., Faries D., Prince J., Faraone S.V., Rea J., Witcher J., and Zervas S. An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 11 (2001) 251-265
21. Tiihonen J., Kuoppasalmi K., Föhr J., Tuomola P., Kuikanmäki O., Vorma H., Sokero P., Haukka J., and Meririnne E. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am. J. Psychiatry 164 (2007) 160-162
22. Wee S., and Woolverton W.L. Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine. Drug Alcohol Depend. 75 (2004) 271-276
23. Wernicke J.F., Faries D., Girod D., Brown J.W., Gao H., Kelsey D., Quinatna H., Lipetz R., Michelson D., and Heiligenstein J. Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Saf. 26 (2003) 729-740